MINERVA SURGICAL INC (UTRS) Stock Price, Quote, News and Overview
NASDAQ:UTRS - Nasdaq - US60343F2056 - Common Stock - Currency: USD
UTRS Quote, Performance and Key Statistics
1.48
-0.07 (-4.52%)
The current stock price of UTRS is 1.48 USD. In the past month the price decreased by -5.13%. In the past year, price decreased by -66.88%.
UTRS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About UTRS
Company Profile
Minerva Surgical Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Redwood City, California and currently employs 174 full-time employees. The company went IPO on 2021-10-22. Minerva Surgical, Inc. is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. Its Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies. The company offers a range of solutions, such as the Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Tissue Removal System (Symphion), and Resectr Tissue Resection Device (Resectr). Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology.
Company Info
MINERVA SURGICAL INC
101 Saginaw Drive
Redwood City CALIFORNIA US
Employees: 174
Company Website: https://minervasurgical.com/
Phone: 16502843500
MINERVA SURGICAL INC / UTRS FAQ
What is the stock price of MINERVA SURGICAL INC today?
The current stock price of UTRS is 1.48 USD. The price decreased by -4.52% in the last trading session.
What is the ticker symbol for MINERVA SURGICAL INC stock?
The exchange symbol of MINERVA SURGICAL INC is UTRS and it is listed on the Nasdaq exchange.
On which exchange is UTRS stock listed?
UTRS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MINERVA SURGICAL INC stock?
7 analysts have analysed UTRS and the average price target is 3.06 USD. This implies a price increase of 106.76% is expected in the next year compared to the current price of 1.48. Check the MINERVA SURGICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MINERVA SURGICAL INC worth?
MINERVA SURGICAL INC (UTRS) has a market capitalization of 13.14M USD. This makes UTRS a Nano Cap stock.
How many employees does MINERVA SURGICAL INC have?
MINERVA SURGICAL INC (UTRS) currently has 174 employees.
What are the support and resistance levels for MINERVA SURGICAL INC (UTRS) stock?
MINERVA SURGICAL INC (UTRS) has a resistance level at 2.8. Check the full technical report for a detailed analysis of UTRS support and resistance levels.
Is MINERVA SURGICAL INC (UTRS) expected to grow?
The Revenue of MINERVA SURGICAL INC (UTRS) is expected to grow by 2.99% in the next year. Check the estimates tab for more information on the UTRS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MINERVA SURGICAL INC (UTRS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of UTRS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of UTRS, evaluating the profitability, health, valuation and growth aspects
- MINERVA SURGICAL INC (UTRS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MINERVA SURGICAL INC (UTRS) Sales and EPS estimates to see what analysts future expectations are.
- MINERVA SURGICAL INC (UTRS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MINERVA SURGICAL INC (UTRS) Insider and Institutional Ownership to learn about the owners and their transactions.
- MINERVA SURGICAL INC (UTRS) Stock Chart to make your own analysis
- MINERVA SURGICAL INC (UTRS) Latest news and press-releases to stay up to date.
Does MINERVA SURGICAL INC (UTRS) stock pay dividends?
UTRS does not pay a dividend.
When does MINERVA SURGICAL INC (UTRS) report earnings?
MINERVA SURGICAL INC (UTRS) will report earnings on 2024-03-19, after the market close.
What is the Price/Earnings (PE) ratio of MINERVA SURGICAL INC (UTRS)?
MINERVA SURGICAL INC (UTRS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-8.21).
What is the Short Interest ratio of MINERVA SURGICAL INC (UTRS) stock?
The outstanding short interest for MINERVA SURGICAL INC (UTRS) is 0% of its float. Check the ownership tab for more information on the UTRS short interest.
UTRS Technical Analysis
UTRS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to UTRS. UTRS may be in some trouble as it scores bad on both profitability and health.
UTRS Financial Highlights
Over the last trailing twelve months UTRS reported a non-GAAP Earnings per Share(EPS) of -8.21. The EPS increased by 58.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.95% | ||
| ROE | -164.78% | ||
| Debt/Equity | 1.37 |
UTRS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to UTRS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 82.41% and a revenue growth 2.99% for UTRS